Yongqiang Qi

Key Laboratory Of Laparoscopic Technology Of Zhejiang Province, Sir Run Run Shaw Hospital
Hangzhou, 310016, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Correction: STUB1-mediated K63-linked ubiquitination of UHRF1 promotes the progression of cholangiocarcinoma by maintaining DNA hypermethylation of PLA2G2A.

Correction: STUB1-mediated K63-linked ubiquitination of UHRF1 promotes the progression of cholangiocarcinoma by maintaining DNA hypermethylation of PLA2G2A.

Journal: Journal of experimental & clinical cancer research : CR

Published: October 07, 2024

PPM1G Inhibits Epithelial-Mesenchymal Transition in Cholangiocarcinoma by Catalyzing TET1 Dephosphorylation for Destabilization to Impair Its Targeted Demethylation of the CLDN3 Promoter.

PPM1G Inhibits Epithelial-Mesenchymal Transition in Cholangiocarcinoma by Catalyzing TET1 Dephosphorylation for Destabilization to Impair Its Targeted Demethylation of the CLDN3 Promoter.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: June 30, 2024

STUB1-mediated K63-linked ubiquitination of UHRF1 promotes the progression of cholangiocarcinoma by maintaining DNA hypermethylation of PLA2G2A.

STUB1-mediated K63-linked ubiquitination of UHRF1 promotes the progression of cholangiocarcinoma by maintaining DNA hypermethylation of PLA2G2A.

Journal: Journal of experimental & clinical cancer research : CR

Published: June 03, 2024

MBD2 regulates the progression and chemoresistance of cholangiocarcinoma through interaction with WDR5.

MBD2 regulates the progression and chemoresistance of cholangiocarcinoma through interaction with WDR5.

Journal: Journal of experimental & clinical cancer research : CR

Published: May 25, 2024

SMAD Proteins in TGF-β Signalling Pathway in Cancer: Regulatory Mechanisms and Clinical Applications.

SMAD Proteins in TGF-β Signalling Pathway in Cancer: Regulatory Mechanisms and Clinical Applications.

Journal: Diagnostics (Basel, Switzerland)

Published: July 08, 2023

Bone Lesion-Derived Extracellular Vesicles Fuel Prometastatic Cascades in Hepatocellular Carcinoma by Transferring ALKBH5-Targeting miR-3190-5p.

Bone Lesion-Derived Extracellular Vesicles Fuel Prometastatic Cascades in Hepatocellular Carcinoma by Transferring ALKBH5-Targeting miR-3190-5p.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: December 01, 2022

The H2A.Z-KDM1A complex promotes tumorigenesis by localizing in the nucleus to promote SFRP1 promoter methylation in cholangiocarcinoma cells.

The H2A.Z-KDM1A complex promotes tumorigenesis by localizing in the nucleus to promote SFRP1 promoter methylation in cholangiocarcinoma cells.

Journal: BMC cancer

Published: June 27, 2022

Autophagy-Related Gene Pairs Signature for the Prognosis of Hepatocellular Carcinoma.

Autophagy-Related Gene Pairs Signature for the Prognosis of Hepatocellular Carcinoma.

Journal: Frontiers in molecular biosciences

Published: February 20, 2021

Exosomal Long Non-Coding RNA: Interaction Between Cancer Cells and Non-Cancer Cells.

Exosomal Long Non-Coding RNA: Interaction Between Cancer Cells and Non-Cancer Cells.

Journal: Frontiers in oncology

Published: October 15, 2020

miR-631 Inhibits Intrahepatic Metastasis of Hepatocellular Carcinoma by Targeting PTPRE.

miR-631 Inhibits Intrahepatic Metastasis of Hepatocellular Carcinoma by Targeting PTPRE.

Journal: Frontiers in oncology

Published: August 11, 2020

CyclinD1 inhibits dicer and crucial miRNA expression by chromatin modification to promote the progression of intrahepatic cholangiocarcinoma.

CyclinD1 inhibits dicer and crucial miRNA expression by chromatin modification to promote the progression of intrahepatic cholangiocarcinoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: May 20, 2019

High PLK4 expression promotes tumor progression and induces epithelial‑mesenchymal transition by regulating the Wnt/β‑catenin signaling pathway in colorectal cancer.

High PLK4 expression promotes tumor progression and induces epithelial‑mesenchymal transition by regulating the Wnt/β‑catenin signaling pathway in colorectal cancer.

Journal: International journal of oncology

Published: July 23, 2017

Showing 1-12 of 16

Last Updated: 09/26/2026